Survival and Long-Term Outcomes of Children Who Survived after End-of-Life Decisions in a Neonatal Intensive Care Unit.

bioethics decision making ethics high-risk pregnancy neonatal outcomes neonatology neurodevelopmental impairment palliative care pediatrics prematurity withholding and withdrawing life-sustaining interventions

Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
08 2023
Historique:
received: 10 10 2022
revised: 10 02 2023
accepted: 21 03 2023
medline: 28 8 2023
pubmed: 20 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

To investigate long-term outcomes of infants who survive despite life-and-death discussions with families and a decision to withdraw or withhold life-sustaining interventions (WWLST) in one neonatal intensive care unit. Medical records for neonatal intensive care unit admissions from 2012 to 2017 were reviewed for presence of WWLST discussions or decisions, as well as the 2-year outcome of all children who survived. WWLST discussions were prospectively recorded in a specific book; follow-up to age 2 years was determined by retrospective chart review. WWLST discussions occurred for 266 of 5251 infants (5%): 151 (57%) were born at term and 115 (43%) were born preterm. Among these discussions, 164 led to a WWLST decision (62%) and 130 were followed by the infant's death (79%). Of the 34 children (21%) surviving to discharge after WWLST decisions, 10 (29%) died before 2 years of age and 11 (32%) required frequent medical follow-up. Major functional limitations were common among survivors, but 8 were classified as functionally normal or with mild-to-moderate functional limitations. When a WWLST decision was made in our cohort, 21% of the infants survived to discharge. By 2 years of age, the majority of these infants had died or had major functional limitations. This highlights the uncertainty of WWLST decisions during neonatal intensive care and the importance of ensuring that parents are informed of all possibilities. Additional studies including longer-term follow-up and ascertaining the family's views will be important.

Identifiants

pubmed: 37076039
pii: S0022-3476(23)00249-4
doi: 10.1016/j.jpeds.2023.113422
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113422

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to disclose.

Auteurs

Béatrice Boutillier (B)

Neonatal Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Hôpital universitaire Robert-Debré, Université de Paris Cité, Paris, France; Division of Neonatology, Centre de recherche, CHU Sainte-Justine Research Center, CHU Sainte-Justine, Montréal, Canada. Electronic address: beatrice.boutillier@orange.fr.

Valérie Biran (V)

Neonatal Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Hôpital universitaire Robert-Debré, Université de Paris Cité, Paris, France; Inserm UMR 1141 Neurodiderot, Université de Paris Cité, Hôpital Robert-Debré, Paris, France.

Annie Janvier (A)

Division of Neonatology, Centre de recherche, CHU Sainte-Justine Research Center, CHU Sainte-Justine, Montréal, Canada; Department of Pediatrics, Université de Montréal, Montréal, Canada; Bureau de l'éthique Clinique (BEC), Université de Montréal, Montréal, Canada; Unité d'éthique clinique, Unité de soins palliatifs, CHU Sainte-Justine, Montréal, Canada.

Keith J Barrington (KJ)

Division of Neonatology, Centre de recherche, CHU Sainte-Justine Research Center, CHU Sainte-Justine, Montréal, Canada; Department of Pediatrics, Université de Montréal, Montréal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH